UPClytics
Alle Fälle anzeigen

UPC CFI 927/2025

25. Sept. 2025·EP3592333 Einheitspatent · A PHARMACEUTICAL COMPOSITION COMPRISING RACECADOTRIL AND PROCESS FOR PREPARING THE SAME

Verfahrensdetails
Status
Interim Phase
Verfahrensart
Nichtigkeit
Kategorie
Hauptnichtigkeitsklage
Parteien
Kläger
Vertreter
Beklagte
Division
Milan CD
Technologie
  • Chemistry
    Pharmaceuticals
Sprache
English
Erste Entscheidung
13. März 2026
Letzte Entscheidung
19. Mai 2026
Im Vergleich
Die Bilanz des Gerichts für diese Art von Verfahren, gezählt in erstinstanzlichen Entscheidungen. Eine Zahl in Klammern gibt an, auf wie vielen Entscheidungen eine Quote beruht.
Patent nichtigMedian Tage bis zur ersten Entscheidung
Gesamt-UPC37% (34/91)124
Milan CDGesperrtGesperrt
Richter Andrea PostiglioneGesperrtGesperrt
Richter Anna-Lena KleinGesperrtGesperrt
Richter Michael AltGesperrtGesperrt

Vor dem UPC: La Siddhi Consultancy Limited (2 Verfahren)·Athena Pharmaceutiques SAS (2 Verfahren)

Entscheidungen
  • 2026-05-19
    Revocation ActionÖffentlich

    Zusammenfassung: The Court partially granted the claimant's application for a confidentiality order under R. 262a RoP in respect of exhibit MW21. The claimant's primary request for an 'external eyes only' regime was rejected; the auxiliary request was granted with modifications, restricting access to defendants' external representatives and two named natural persons (Head of Legal of Defendant 1 and one Indian external counsel). The defendants' request for access by experts/consultants without naming specific persons was also rejected.

    Rechtsfragen anzeigen (6)
    • Confidentiality protection under R. 262a RoP and Art. 58 UPCA
    • Scope of 'confidentiality club' membership — whether 'external eyes only' regime is permissible
    • Right of defendants to have at least one natural person access confidential evidence (Art. 9.3 Enforcement Directive, R. 262A.6 RoP)
    • Access for non-UPC-representative external legal advisers (Indian counsel) to confidential club
    • Standing under Art. 47.6 UPCA — 'concern by the patent' threshold
    • Inclusion of unnamed experts/consultants in confidentiality regime
  • 2026-03-13
    Revocation ActionÖffentlich

    Zusammenfassung: The Milan Central Division (full panel: Postiglione, Klein, Alt) ordered La Siddhi Consultancy Ltd. to provide security for legal costs of EUR 112,000 in favour of the defendants (Athena Pharmaceutiques and Substipharm) in the revocation action concerning EP 3 592 333. The Court found that La Siddhi's financial situation (thin equity margin of approximately GBP 27,000) gave rise to a legitimate concern that any costs order would not be recoverable. La Siddhi's claim to SME status was found unsubstantiated. Security may be provided by bank deposit or EU-licensed bank guarantee within six weeks.

    Rechtsfragen anzeigen (4)
    • Security for costs (R. 158 RoP)
    • Financial means of claimant
    • SME / micro-enterprise status (R. 370.8 RoP; Commission Recommendation 2003/361/EC)
    • Art. 69.1 UPCA equity considerations
DokumenttitelDatumÖffentlich
Anordnung2026-10-13Nicht öffentlich
Order2026-10-13Öffentlich
Receipt2026-10-09Nicht öffentlich
Cover sheet2026-10-09Nicht öffentlich
Submission Defendant2026-10-09Nicht öffentlich
Mitteilung2026-10-04Nicht öffentlich
Anordnung2026-10-02Nicht öffentlich
Order2026-10-02Nicht öffentlich
Other Documents2026-09-11Nicht öffentlich
Zwischenverfahren eröffnet2026-09-10Nicht öffentlich
Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • Defendants are entitled to have at least one natural person (Head of Legal) admitted to the confidentiality club; excluding all natural persons from defendants would violate their right to an effective remedy and fair trial

    BeklagterRechtsgrundlage: R. 262A.6 RoP; Art. 9.3 Enforcement Directive; UPC_CoA 755/2025 (Sun v Vivo)
  • One Indian external counsel already engaged in the matter should be admitted to the confidentiality club because the defendants demonstrated that Indian counsel is part of the instruction chain for these proceedings

    BeklagterRechtsgrundlage: UPC_CoA_621/2024 (Daedalus v Xiaomi); UPC_CoA_169/2024
  • Auxiliary request limiting access to one named natural person per defendant who is not involved in competitive decision-making is proportionate

    KlägerRechtsgrundlage: R. 262A RoP; Art. 58 UPCA
Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • Primary request for 'external eyes only' / 'attorneys eyes only' regime — claimant failed to show exceptional circumstances justifying exclusion of all natural persons from defendants

    KlägerRechtsgrundlage: R. 262A.6 RoP; Art. 58 UPCA
  • Confidential nature of MW21 and risk of conclusions being drawn are sufficient to justify external eyes only regime

    KlägerRechtsgrundlage: Art. 58 UPCA
  • Document only serves a 'limited procedural purpose' — defendants should not need natural person access

    KlägerRechtsgrundlage: Art. 47.6 UPCA
  • Two Indian counsel should be admitted to the confidentiality club

    BeklagterRechtsgrundlage: R. 262A RoP
  • Experts, consultants and advisers should be granted access to unredacted MW21 upon request without naming specific persons in advance

    BeklagterRechtsgrundlage: R. 262A RoP
  • Claimant itself and the Registry should be expressly named in the confidentiality order — claimant showed no legitimate interest in restricting its own access

    KlägerRechtsgrundlage: R. 262A RoP
  • Persons admitted to confidentiality club must return or destroy copies at end of proceedings

    KlägerRechtsgrundlage: R. 262A RoP
  • Defendants should bear costs of the R. 262a application proceedings

    KlägerRechtsgrundlage: No legal basis for cost decision in R. 262A RoP proceedings